Hepion Pharmaceuticals, Inc. logo

HEPAHepion Pharmaceuticals, Inc.

HEPA Stock Price, Valuation & Chart | Hepion Pharmaceuticals, Inc.

Compare

HEPA Historical price chart

HEPA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization827.28K
PE Ratio-0.03
EPS-2.34
Trading Volume12.77K
Today's High/Low0.08/0.06
Dividend Yield0.00
52 Week High/Low0.11/0.03
Shares Outstanding11.64M
HEPA Financial Statement
HEPA Analyst ratings
HEPA Analysis & performance metrics

HEPA Company profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is…

HEPA Management team

Management
John Patrick Brancaccio CPACEO
Interim Chief Executive Officer, Interim Chief Financial Officer & Chairman of the Board
Sharen PyatetskayaCTO
Director of Investor Relations
Total 2 executives

HEPA Frequently asked questions

What is Hepion Pharmaceuticals, Inc. (HEPA) Stock Price?

Current stock price of Hepion Pharmaceuticals, Inc. (HEPA) stock is $0.070. The stock price is -5.27% lower in the session. The intraday range can be seen from this page. Volume of Hepion Pharmaceuticals, Inc. (HEPA) stock is 12.77K.

Last updated at 02 Sept 2026, 07:45 pm.

Why is the Hepion Pharmaceuticals, Inc. (HEPA) stock price going up or down today?

The stock price of Hepion Pharmaceuticals, Inc. (HEPA) can change with earnings, company news, and overall market sentiment. Hepion Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Hepion Pharmaceuticals, Inc. stock expensive at its current price?

Whether Hepion Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for HEPA on this page is -0.03. EPS on this page is -2.34. Compare those figures with peers and growth expectations before deciding if the current Hepion Pharmaceuticals, Inc. price is justified.

How has the stock price of Hepion Pharmaceuticals, Inc. (HEPA) performed historically?

Historical performance for Hepion Pharmaceuticals, Inc. (HEPA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how HEPA reacted to past earnings and market events.

Should I buy Hepion Pharmaceuticals, Inc. (HEPA) stock, at this price?

Buying Hepion Pharmaceuticals, Inc. (HEPA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.